Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myasthenia Gravis × Exercise × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 194 Breast Neoplasms 111 Neoplasms 82 Fatigue 29 Prostatic Neoplasms 27 Colorectal Neoplasms 20 Obesity 19 Lung Neoplasms 17 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Lymphedema 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Pancreatic Neoplasms 9 Multiple Myeloma 9 Lymphoma 9 Hematologic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Head and Neck Neoplasms 8 Cardiotoxicity 8 Weight Loss 7 Stomach Neoplasms 6 Leukemia 6 Insulin Resistance 6 Brain Neoplasms 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Esophageal Neoplasms 5 Endometrial Neoplasms 5

Interventions

telitacicept 2 talquetamab 1 bu-zhong-yi-qi-tang 1 Walk Test 1 Sugammadex 1 Robotic Surgical Procedures 1 Rituximab 1 Psychodrama 1 Population Groups 1 Plasma Exchange 1 Neostigmine 1 Mycophenolic Acid 1 Muscle Stretching Exercises 1 Immunoglobulins, Intravenous 1 Immunoglobulins 1 Exercise 1 Control Groups 1 Cognitive Behavioral Therapy 1 Art Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05992025 2025-03-30

DIG-MG

Uppsala University

Phase NA Completed

Fatigue, Motor Activity, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡